What is Clinomic?
Founded in 2019, Clinomic has established itself as a leader in the digital transformation of hospital operations. The company specializes in AI-driven solutions designed specifically for the high-stakes environment of intensive care medicine. Its flagship platform, Mona, integrates disparate patient data streams to provide actionable insights, thereby streamlining clinical workflows and facilitating remote telemedicine consultations. By addressing the complexities of critical care, Clinomic aims to bridge the gap between raw medical data and improved patient outcomes, effectively optimizing the delivery of care in resource-constrained hospital settings.
How much funding has Clinomic raised?
Clinomic has raised a total of $25.6M across 1 funding round:
Series B
$25.6M
Series B (2025): $25.6M with participation from DeepTech & Climate Fonds
Key Investors in Clinomic
DeepTech & Climate Fonds
DeepTech & Climate Fonds is a prominent venture capital entity managing 1 billion EUR, dedicated to supporting early growth ventures in the DeepTech and ClimateTech sectors across Europe.
What's next for Clinomic?
Looking ahead, the strategic deployment of the $25.6M will likely focus on scaling the Clinomic Group's subsidiaries, which are dedicated to telemedicine and advanced data analytics. As the company continues to navigate the regulatory and technical challenges of the MedTech sector, the focus will remain on expanding the reach of the Mona platform across international markets. By prioritizing the integration of digital transformation tools into existing hospital infrastructures, Clinomic is well-positioned to drive long-term value for healthcare providers and patients alike, solidifying its role as a critical player in the evolution of smart, data-informed intensive care.
See full Clinomic company page
